Suggestions
Claus Augel
Professional Background
Claus Augel is a well-respected figure in the pharmaceutical and biotechnology industry, bringing with him a wealth of experience and a remarkable background in key account management and analysis within neuroscience. His extensive career spans several esteemed organizations, including Mylan, Roche, Teva Deutschland, Merck, Shire Pharmaceuticals, UCB, and Orion Pharma. Through his roles, he has cultivated deep connections within the industry, excelled in client relations, and continued to deliver innovative solutions to healthcare providers.
Currently, Claus serves as the Nationaler Key-Account-Manager (National Key Account Manager) at Mylan, where he employs his strategic acumen to strengthen partnerships with key clients. His ability to navigate complex challenges and manage high-value accounts has made him a crucial asset to Mylan's operations in the competitive landscape of pharmaceuticals.
Previously, Claus worked as an In Field Analyst in Neuroscience at Roche, a company renowned for its commitment to research and development in the field of healthcare. In this position, he played a critical role in analyzing market trends and data, contributing insights that drove the company's strategic initiatives. His analytical prowess has allowed him to make informed decisions that align healthcare solutions with patient needs effectively.
Before his tenure at Roche, Claus served as a Key Account Manager at various esteemed pharmaceutical companies such as Teva Deutschland, Merck, and Shire Pharmaceuticals. In these roles, he was responsible for managing significant accounts, negotiating contracts, and ensuring the delivery of healthcare solutions that meet the specific needs of clients and patients alike. His diverse experience encompasses cardiology, neuroscience, and other vital areas of healthcare, enhancing his understanding of the complexities of patient care.
Claus started his career in the field as an Außendienstmitarbeiter Fachaußendienst (Field Service Representative) at UCB, focusing on neuroscience. His early experience laid the groundwork for a successful career, providing him with the practical skills necessary for his future endeavors in the pharmaceutical landscape.
Education and Achievements
Claus Augel has a solid educational foundation that complements his extensive professional experience. He studied Cand. med. (Candidate of Medicine) and successfully completed the 2. Staatsexamen (Second State Examination) at Universität Bonn, one of Germany's leading research universities. This rigorous medical education provided Claus with a comprehensive understanding of healthcare and medical ethics, which he continues to apply in his professional roles.
In addition to his medical studies, Claus pursued a Diplom Betriebswirt (Diploma in Business Administration) at the Verwaltungs und Wirtschaftsakademie Mannheim, where he achieved an outstanding grade of 1.3. This qualification has equipped him with essential business skills that are invaluable in the fast-paced world of pharmaceuticals and account management.
Notably, Claus has also completed the IHK Prüfung zum Staatlich geprüften Pharmareferenten (IHK Examination for State Certified Pharmaceutical Representatives), further demonstrating his commitment to professional development and expertise in the pharma industry. This certification reflects his dedication to upholding the highest standards of professionalism and knowledge in a constantly changing marketplace.
Throughout his career, Claus has consistently showcased his ability to foster relationships with healthcare practitioners and organizations. His expertise and dedication have significantly contributed to the growth and success of the companies he has worked with.
Achievements
Claus Augel's career is marked by numerous achievements that highlight his expertise in managing key accounts and his analytical capabilities in the pharmaceutical industry. His leadership qualities and commitment to excellence have led to impactful results within organizations.
As National Key Account Manager at Mylan, Claus has been instrumental in developing strategic partnerships that enable the company to enhance its service offerings and reach new markets. His strategic insight allows Mylan to respond proactively to the evolving needs of healthcare professionals and patients, making a tangible difference in patient care.
While working at Roche, Claus's ability to synthesize complex data into actionable insights has contributed to the development of successful marketing strategies and product launches. His work has supported the company's mission to innovate and advance healthcare solutions in neuroscience and beyond.
Claus’s tenure across various companies demonstrates a consistent pattern of driving growth and achieving objectives in highly competitive environments. His effectiveness in roles at Teva Deutschland, Merck, and Shire Pharmaceuticals signifies a deep understanding of the industry dynamics and patient-centric approach to healthcare.
In conclusion, Claus Augel is a dynamic and accomplished professional within the pharmaceutical sector, driven by a passion for improving patient outcomes and executing effective solutions for healthcare providers. With a robust educational background and an exceptional record of achievement, he is poised to continue making significant contributions to the industry throughout his career.